Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
15.93
+0.13 (0.82%)
At close: Aug 1, 2025, 4:00 PM
15.92
-0.01 (-0.06%)
After-hours: Aug 1, 2025, 7:32 PM EDT
Achilles Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$43.71
Upside
+174.39%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +402.20% | May 20, 2025 |
Citigroup | Citigroup | Hold Maintains $21 → $17 | Hold | Maintains | $21 → $17 | +6.72% | May 13, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +276.65% | May 13, 2025 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $51 → $38 | Strong Buy | Reiterates | $51 → $38 | +138.54% | Feb 14, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +402.20% | Feb 12, 2025 |
RBC Capital | RBC Capital | Buy Reiterates $42 | Buy | Reiterates | $42 | +163.65% | Feb 11, 2025 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +276.65% | Feb 11, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +402.20% | Jan 23, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $80 | Strong Buy | Reiterates | $80 | +402.20% | Dec 20, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +276.65% | Dec 12, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 → $80 | Strong Buy | Maintains | $60 → $80 | +402.20% | Dec 3, 2024 |
Bernstein | Bernstein | Hold Maintains $27 → $24 | Hold | Maintains | $27 → $24 | +50.66% | Nov 29, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $62 → $45 | Buy | Maintains | $62 → $45 | +182.49% | Nov 27, 2024 |
Citigroup | Citigroup | Hold Maintains $27 → $26 | Hold | Maintains | $27 → $26 | +63.21% | Nov 27, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +276.65% | Nov 27, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +276.65% | Nov 20, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.